Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Crohn's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06257706
What this trial is testing

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohn's DiseaseCrohn DiseaseDisease Crohn
Alimentiv Inc. 304
Testing effectiveness (Phase 2)Ended earlyNCT00792740
What this trial is testing

Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Italfarmaco 51
Large-scale testing (Phase 3)WithdrawnNCT04643483
What this trial is testing

Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
UCB Biopharma SRL
Early research (Phase 1)Study completedNCT02148185
What this trial is testing

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Tanabe Pharma Corporation 1
Large-scale testing (Phase 3)Study completedNCT00206674
What this trial is testing

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 286
Not applicableStudy completedNCT03941184
What this trial is testing

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Who this might be right for
SCADAddison DiseaseAnkylosing Spondylitis+26 more
Mayo Clinic 114
Testing effectiveness (Phase 2)Ended earlyNCT01540292
What this trial is testing

Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders

Who this might be right for
Crohn's Disease
University of Liege 13
Testing effectiveness (Phase 2)Study completedNCT03681067
What this trial is testing

A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
University of Birmingham 5
Large-scale testing (Phase 3)Looking for participantsNCT06227910
What this trial is testing

Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 396
Testing effectiveness (Phase 2)Study completedNCT03395184
What this trial is testing

Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Pfizer 244
Large-scale testing (Phase 3)Study completedNCT00783692
What this trial is testing

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Millennium Pharmaceuticals, Inc. 1,116
Early research (Phase 1)Ended earlyNCT03169894
What this trial is testing

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn DiseaseUlcerative Colitis
Avalo Therapeutics, Inc. 8
Not applicableUnknownNCT06573944
What this trial is testing

IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study

Who this might be right for
Crohn's DiseaseUpadacitinibIntestinal Ultrasound+1 more
The Third Xiangya Hospital of Central South University 34
Large-scale testing (Phase 3)Study completedNCT03926130
What this trial is testing

Mirikizumab (LY3074828) in Participants With Crohn's Disease

Who this might be right for
Crohn's Disease
Eli Lilly and Company 1,158
Large-scale testing (Phase 3)Study completedNCT00338650
What this trial is testing

Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

Who this might be right for
Crohn's Disease
Abbott 1,000
Testing effectiveness (Phase 2)WithdrawnNCT01836289
What this trial is testing

High-dose Cyclophosphamide for Severe Refractory Crohn Disease

Who this might be right for
Crohn's DiseaseCrohn Disease
Johns Hopkins University
Testing effectiveness (Phase 2)Study completedNCT00101946
What this trial is testing

Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 17
Large-scale testing (Phase 3)Looking for participantsNCT05837897
What this trial is testing

Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 408
Post-approval studies (Phase 4)Not Yet RecruitingNCT07059130
What this trial is testing

Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis

Who this might be right for
Crohn Disease (CD)Crohns DiseaseUlcerative Colitis (UC)
Rubix LS 150
Not applicableStudy completedNCT01338740
What this trial is testing

Switching From Adalimumab to Infliximab

Who this might be right for
Crohn's Disease
University Hospital, Ghent 21
Next Page